Small Molecules, Specialty
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
118
NCT03435094
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
Phase: N/A
Role: Lead Sponsor
Start: Feb 25, 2018
Completion: Dec 1, 2022
NCT05751772
Improving Knowledge in Heart Failure Inpatient With Therapeutic Education
Role: Collaborator
Start: Dec 13, 2022
Completion: Jan 31, 2024
Loading map...